DEKA Medical Receives FDA Clearance for the Synchro REPLA:Y®

BRANFORD, CT, February 10th, 2014 – DEKA Medical, Inc., a leading developer and distributor of a wide range of light-based aesthetic systems, today announced that it has recently received clearance from the FDA for its Synchro REPLA:Y®, an innovative aesthetic workstation dedicated, but not limited, to high speed stable long-term, or permanent hair reduction, treatment of PFB, treatment of benign pigmented lesions, treatment of wrinkles and photocoagulation of dermatological vascular lesions.